Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

U.S. stocks open higher despite Ukraine worries; Dow Jones up 0.57%

Published 05/12/2014, 09:42 AM
U.S. stocks rise, markets still focus on Ukraine
UK100
-
US500
-
FCHI
-
DJI
-
DE40
-
STOXX50
-
JP225
-
HK50
-
AAPL
-
AZN
-
BSBAy
-
TFCF
-
PFE
-
WMT
-
HSH
-
CPPRQ
-
AGN_pa
-
M
-
BHC
-
IXIC
-
PF
-

Investing.com - U.S. stocks opened higher on Monday, as trading volumes were expected to remain thin in the absence of any major U.S. economic reports throughout the session, while investors continued to monitor developments in Ukraine.

During early U.S. trade, the Dow 30 climbed 0.57%, the S&P 500 gained 0.60%, while the NASDAQ Composite advanced 0.73%.

Markets were jittery after pro-Russian separatists claimed victory in a weekend referendum on self-rule in eastern Ukraine, fuelling fears that the country is sliding closer to civil war. The vote has been condemned by Ukraine’s government and the West.

European foreign ministers were set to meet in Brussels later Monday to discuss tighter sanctions against Russia.

In the tech sector, Apple (NASDAQ:AAPL) shares rose 0.38%, still supported by reports last week that the iPhone maker is nearing an acquisition of Beats Electronics LLC for $3.2 billion.

In similar news, Rupert Murdoch's British Sky Broadcasting Group (LONDON:BSY) said it is in talks to buy the Italian and German pay-TV assets of Twenty-First Century Fox (NASDAQ:FOX). The deal for control of satellite carriers Sky Italia and Sky Deutschland would reportedly be valued at about $14 billion.

Twenty-First Century Fox, which owns 39% of BSkyB, saw shares surge 3.81% following the news.

Elsewhere, Pfizer (NYSE:PFE) gained 0.83% amid its ongoing attempts to acquire U.K. rival Astrazeneca (LONDON:AZN). Pfizer boss Ian Read was set to appear before a U.K. business select committee on Tuesday alongside Astrazeneca's Pascal Soriot.

In the same sector, the board of Allergan (NYSE:AGN), down 0.84%, turned down an unsolicited offer from Valeant Pharmaceuticals (NYSE:VRX), as it was considered as significantly undervaluing the drug developer. Valeant shares dropped 0.70% at the open of the U.S. trading session.

Hillshire Brands (NYSE:HSH) added to losses, plummeting 3.82%, after the branded foods giant said it would pay about $6.6 billion to purchase Pinnacle Foods (NYSE:PF), whose shares skyrocketed 15.70% following the news.

Other stocks likely to be in focus included Wal-Mart Stores (NYSE:WMT), Macy's (NYSE:M) and JC Penney (NYSE:JCP), scheduled to report quarterly results later in the day.

Across the Atlantic, European stock markets were higher. The DJ Euro Stoxx 50 gained 0.76%, France’s CAC 40 rose 0.28%, Germany's DAX jumped 1.31%, while Britain's FTSE 100 advanced 0.47%.

During the Asian trading session, Hong Kong's Hang Seng jumped 1.82%, while Japan’s Nikkei 225 shed 0.35%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.